ZLB Behring Foundation Appoints New Members to Board of Directors.KING OF PRUSSIA King of Prussia, industrialized suburban area (1990 pop. 18,406), Montgomery co., SE Pa. It has glass and steel fabricating, food processing, printing and publishing, and varied manufacturing (textiles, liquified petroleum gas, water-treatment and electrical , Pa. -- The ZLB ZLB Zero Length Body ZLB Zero Length Bit Behring Foundation for Research and Advancement of Patient Health today announced the appointment of two new board members, Dr. Leonard A. Valentino of Rush University Medical Center in Chicago and Beatrice Young Pierce, RN, MSN (1) (MicroSoft Network) A family of Internet-based services from Microsoft, which includes a search engine, e-mail (Hotmail), instant messaging (Windows Live Messaging) and a general-purpose portal with news, information and shopping (MSN Directory). , a bleeding disorders advocate in Rancho Santa Fe, California Rancho Santa Fe is an unincorporated census-designated place in San Diego County, California, United States. The population was 3,252 at the 2000 census. It is the highest income community in the United States with at least 2,500 households. . Both appointees will play a significant role in the selection of Foundation grant recipients. Governed by an independent Advisory Council that has the sole authority to award grants, the ZLB Behring Foundation is a non-profit organization dedicated exclusively to charitable, scientific and educational purposes that advance the standard of care for persons affected by bleeding disorders such as hemophilia and von Willebrand Disease Von Willebrand Disease Definition Von Willebrand disease is caused by a deficiency or an abnormality in a protein called von Willebrand factor and is characterized by prolonged bleeding. . "It is a pleasure to welcome such diversely experienced people to our Board of Directors," said Paul Perreault, Vice Director of the ZLB Behring Foundation. "The decades of leadership and commitment to the bleeding disorders community that Dr. Valentino and Mrs. Pierce bring will certainly add value, strength and depth to our organization." Dr. Valentino brings clinical expertise to the Foundation with nearly 20 years of experience and research in the bleeding disorders community. A graduate of Creighton University Medical School, Dr. Valentino is board certified board certified, adj the status of a dental specialist such as an orthodontist who has become a board diplomate by successfully completing the certification program of the recognized certification board in that area of practice. in pediatrics and hematology/oncology and practices at Rush University Medical Center in Chicago, Illinois. His clinical and research interests include hemophilia, bleeding disorders, thrombosis and platelet disorders. Throughout his career, he has received various honors and awards, such as the Mead Johnson Award in recognition of teaching excellence and the William A. Albano Award in outstanding student research. He is also a member of several professional societies, including the American Society of Hematology, Metastasis metastasis /me·tas·ta·sis/ (me-tas´tah-sis) pl. metas´tases 1. transfer of disease from one organ or part of the body to another not directly connected with it, due either to transfer of pathogenic microorganisms or to Research Society, National Hemophilia Foundation, and World Federation of Haemophilia. As the wife of an individual with severe Factor VIII factor VIII n. A factor in the clotting of blood, a deficiency of which is associated with hemophilia A. Also called antihemophilic factor, antihemophilic globulin, antihemophilic globulin A, hemophilia, Beatrice Young Pierce RN, MSN, has a personal interest in and passion for the advancement in treatment of bleeding disorders. Pierce has volunteered in the hemophilia community at local, regional and national levels for over 20 years. Through the National Hemophilia Foundation alone, she has served on several committees and held positions including co-chair of the Blood Safety Working Group; co-chair of the Annual Meeting Working Group; chair of the Education Committee; and vice-chair of the Board of Directors. Pierce has also served on two U.S. Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) Advisory Committees. For more information on the Foundation, visit www.zlbbehringfoundation.com. About the ZLB Behring Foundation Founded in 2001 as an independent, non-profit corporation, the ZLB Behring Foundation for Research and Advancement of Patient Health is the only corporate foundation dedicated exclusively to charitable, scientific and educational purposes designed to advance the standard of care for persons affected by bleeding disorders. The ZLB Behring Foundation is governed by an Advisory Council consisting of healthcare professionals and advocates who are renowned for their dedication to the bleeding disorders community. The Advisory Council has the sole authority to award all grants. About ZLB Behring ZLB Behring is a global leader in the plasma protein plasma protein n. Any of the various dissolved proteins of blood plasma, including antibodies and blood-clotting proteins, that act by holding fluid in blood vessels by osmosis. biotherapeutics industry. Its comprehensive line of therapies include products for the treatment of hemophilia and other coagulation disorders Coagulation Disorders Definition Coagulation disorders deal with disruption of the body's ability to control blood clotting. The most commonly known coagulation disorder is hemophilia, a condition in which patients bleed for long periods of time before , immunoglobulins for the prevention and treatment of immune disorders, treatments that inhibit the formation of blood clots, wound-healing agents used during major surgical procedures, and plasma expanders for the treatment of a variety of conditions such as shock, burns and circulatory disorders. Additionally, ZLB Behring operates one of the world's largest, fully-owned plasma collection networks. ZLB Behring is a subsidiary of CSL Limited, a bio-pharmaceutical company which operates worldwide from its headquarters in Melbourne, Australia. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion